Pu Yu

No.1 Jianshe East Road
Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Weissella cibaria-derived dextran alleviates cisplatin-induced kidney injury by remodeling the gut microbiota.

Weissella cibaria-derived dextran alleviates cisplatin-induced kidney injury by remodeling the gut microbiota.

Journal: BMC microbiology

Published: March 19, 2026

Predictive model based on folate receptor-positive circulating tumor cells in neoadjuvant immunochemotherapy for esophageal cancer.

Predictive model based on folate receptor-positive circulating tumor cells in neoadjuvant immunochemotherapy for esophageal cancer.

Journal: Journal of gastrointestinal oncology

Published: December 29, 2025

Enhancing immunotherapy efficacy in NSCLC through the combined use of phenelzine and Akkermansia muciniphila to regulate gut microbial metabolite 5-HIAA.

Enhancing immunotherapy efficacy in NSCLC through the combined use of phenelzine and Akkermansia muciniphila to regulate gut microbial metabolite 5-HIAA.

Journal: Journal for immunotherapy of cancer

Published: July 30, 2025

CD27 expression is a clinically accessible biomarker for predicting immunotherapy response in melanoma.

CD27 expression is a clinically accessible biomarker for predicting immunotherapy response in melanoma.

Journal: NPJ precision oncology

Published: June 09, 2025

BTLA promoter hypomethylation correlates with enhanced immune cell infiltration, favorable prognosis, and immunotherapy response in melanoma.

BTLA promoter hypomethylation correlates with enhanced immune cell infiltration, favorable prognosis, and immunotherapy response in melanoma.

Journal: Journal for immunotherapy of cancer

Published: February 17, 2025

Efficacy and safety of camrelizumab plus Lacticaseibacillus paracasei in the treatment of advanced esophageal squamous cell carcinoma: A single-arm, single-center, exploratory trial.

Efficacy and safety of camrelizumab plus Lacticaseibacillus paracasei in the treatment of advanced esophageal squamous cell carcinoma: A single-arm, single-center, exploratory trial.

Journal: Cancer pathogenesis and therapy

Published: September 19, 2024

The anticancer mechanisms of exopolysaccharide from Weissella cibaria D-2 on colorectal cancer via apoptosis induction.

The anticancer mechanisms of exopolysaccharide from Weissella cibaria D-2 on colorectal cancer via apoptosis induction.

Journal: Scientific reports

Published: September 11, 2023

Exopolysaccharide from Weissella confusa J4-1 inhibits colorectal cancer via induction of cell cycle arrest.

Exopolysaccharide from Weissella confusa J4-1 inhibits colorectal cancer via induction of cell cycle arrest.

Journal: International journal of biological macromolecules

Published: September 17, 2022

Feasibility and tolerability of sintilimab plus anlotinib as the second-line therapy for patients with advanced biliary tract cancers: An open-label, single-arm, phase II clinical trial.

Feasibility and tolerability of sintilimab plus anlotinib as the second-line therapy for patients with advanced biliary tract cancers: An open-label, single-arm, phase II clinical trial.

Journal: International journal of cancer

Published: July 25, 2022

Oral nanozyme-engineered probiotics for the treatment of ulcerative colitis.

Oral nanozyme-engineered probiotics for the treatment of ulcerative colitis.

Journal: Journal of materials chemistry. B

Published: May 03, 2022

B4GALNT2 Gene Promotes Proliferation, and Invasiveness and Migration Abilities of Model Triple Negative Breast Cancer (TNBC) Cells by Interacting With HLA-B Protein.

B4GALNT2 Gene Promotes Proliferation, and Invasiveness and Migration Abilities of Model Triple Negative Breast Cancer (TNBC) Cells by Interacting With HLA-B Protein.

Journal: Frontiers in oncology

Published: June 09, 2021

An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors.

An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors.

Journal: Bioscience reports

Published: July 01, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026